Martwica kości żuchwy zaopatrzonej implantami w przebiegu terapii bisfosfonianami

Martwica kości żuchwy zaopatrzonej implantami w przebiegu terapii bisfosfonianami
MS 2020; 11: 12-15.
Jurand Mackiewicz, Łukasz Książek, Anna Starzyńska

Streszczenie
Bardzo ważnym warunkiem stomatologicznego leczenia implantologicznego jest diagnostyka preimplantologiczna. Na przykładzie pacjentki, która celowo nie podała w wywiadzie aktualnego leczenia przeciwnowotworowego, przedstawiono leczenie chirurgiczne powikłań poimplantacyjnych.

Abstract
Preimplantation diagnostics is a crucial part of any implantoprosthetic treatment. In this case a 50‑year
old female patient presented a non‑complete medical history, skipping her cancer treatment and a treatment plan of implantation complications is presented.

Hasła indeksowe: implanty stomatologiczne, diagnostyka preimplantologiczna, choroba nowotworowa, bisfosfoniany
Key words: dental implants, preimplantation diagnostics, neoplasm disease, bisphosphonates

Piśmiennictwo:                                                                                              

  1. Fedele S, Bedogni G, Scoletta M i wsp. Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed. Br J Oral Maxillofac Surg. 2015; 53(1): 13-17.
  2. Migliorati CA. Bisphosphanates and oral cavity avascular bone necrosis. J Clin Oncol. 2003; 21(22): 4253-4254.
  3. Wessel JH, Dodson TB, Zavras AI. Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw. A case-control study. J Oral Maxillofac Surg. 2008; 66(4): 625-631.
  4. Jadu F, Lee L, Pharoah M i wsp. A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients. Ann Oncol. 2007; 18(12): 2015-2019.
  5. Guggenberger R, Fischer DR, Metzler P i wsp. Bisphosphonate-induced osteonecrosis of the jaw. Comparison of disease extent on contrast-enhanced MR imaging, [18F] fluoride PET/CT, and conebeam CT imaging. AJNR Am J Neuroradiol. 2013; 34(6): 1242-1247.
  6. Stockmann P, Hinkmann FM, Lell MM i wsp. Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Investig. 2010; 14(3): 311-317.
  7. Hanasono MM, Militsakh ON, Richmon JD i wsp. Mandibulectomy and free flap reconstruction for bisphosphonate-related osteonecrosis of the jaws. JAMA Otolaryngol Head Neck Surg. 2013; 139(11): 1135-1142.
  8. Ruggiero SL, Dodson TB, Fantasia J i wsp.; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw – 2014 update. J Oral Maxillofac Surg. 2014; 72(10): 1938-1956.
  9. Khan AA, Morrison A, Hanley DA i wsp.; International Task Force on Osteonecrosis of the Jaw. Diagnosis and management of osteonecrosis of the jaw. A systematic review and international consensus. J Bone Miner Res. 2015; 30(1): 3-23.
  10. Jasper V, Laurence V, Maximiliaan S, Ferri I, Nicont R, Constantinus P. Medication-relared osteonecrosis of the jaw (MRONJ) stage III: conservative and conservative surgical approaches versus an aggressive surgical intervention: A systematic J Craniomaxillofac Surgery. 2020; 48(4): 435-443.
  11. Jurkowski P, Mierzwińska-Nastalska E, Kostrzewa-Janicka J. Zastosowanie biochemicznych markerów obrotu kostnego w medycynie ogólnej i stomatologii. Dent Med 2010; 47(2): 199-205.
  12. Miksad RA, Lai KC, Dodson TB i wsp. Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist. 2011; 16(1): 121-132.
.
poprzedni artykuł